Although the pharmacology of VPA is still not understood completely, the drug seems to enhance activity of the inhibitory neurotransmitter gamma-aminobutyric acid (GABA), impair activity of the excitatory neurotransmitter glutamate, and block sodium channels
For prescribers across functional medicine, integrative oncology, aesthetics, and neurology, choosing the right compounding partner is as clinically significant as the therapy itself
Targeting lung cancer with clinically relevant EGFR mutations using anti-EGFR RNA aptamer
of OptiHealth Institute, you will be given detailed instructions and for each treatment and how they each are administered
The products are not medicines or drugs and they have not been approved by the FDA to prevent, treat, diagnose, mitigate, or cure any disease, ailment or medical condition
Deep recovery and sleep enhancement Sustained GH levels mean better sleep quality every night